Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.04
EVHC's Cash to Debt is ranked lower than
87% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 0.33 vs. EVHC: 0.04 )
Ranked among companies with meaningful Cash to Debt only.
EVHC' s Cash to Debt Range Over the Past 10 Years
Min: 0.03  Med: 0.13 Max: 1.51
Current: 0.04
0.03
1.51
Equity to Asset 0.35
EVHC's Equity to Asset is ranked lower than
68% of the 248 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. EVHC: 0.35 )
Ranked among companies with meaningful Equity to Asset only.
EVHC' s Equity to Asset Range Over the Past 10 Years
Min: 0.3  Med: 0.53 Max: 0.8
Current: 0.35
0.3
0.8
Interest Coverage 10.26
EVHC's Interest Coverage is ranked higher than
55% of the 213 Companies
in the Global Medical Care industry.

( Industry Median: 7.76 vs. EVHC: 10.26 )
Ranked among companies with meaningful Interest Coverage only.
EVHC' s Interest Coverage Range Over the Past 10 Years
Min: 4.74  Med: 16.88 Max: 28.93
Current: 10.26
4.74
28.93
F-Score: 8
Z-Score: 1.39
M-Score: -2.15
WACC vs ROIC
3.34%
9.99%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 21.76
EVHC's Operating margin (%) is ranked higher than
91% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 6.84 vs. EVHC: 21.76 )
Ranked among companies with meaningful Operating margin (%) only.
EVHC' s Operating margin (%) Range Over the Past 10 Years
Min: 21.76  Med: 31.8 Max: 35.27
Current: 21.76
21.76
35.27
Net-margin (%) 6.06
EVHC's Net-margin (%) is ranked higher than
58% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. EVHC: 6.06 )
Ranked among companies with meaningful Net-margin (%) only.
EVHC' s Net-margin (%) Range Over the Past 10 Years
Min: 3.31  Med: 6.88 Max: 8.52
Current: 6.06
3.31
8.52
ROE (%) 7.74
EVHC's ROE (%) is ranked lower than
57% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 9.67 vs. EVHC: 7.74 )
Ranked among companies with meaningful ROE (%) only.
EVHC' s ROE (%) Range Over the Past 10 Years
Min: 4.03  Med: 9.79 Max: 11.84
Current: 7.74
4.03
11.84
ROA (%) 2.79
EVHC's ROA (%) is ranked lower than
60% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 3.90 vs. EVHC: 2.79 )
Ranked among companies with meaningful ROA (%) only.
EVHC' s ROA (%) Range Over the Past 10 Years
Min: 1.39  Med: 4.07 Max: 6.75
Current: 2.79
1.39
6.75
ROC (Joel Greenblatt) (%) 214.84
EVHC's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 254 Companies
in the Global Medical Care industry.

( Industry Median: 18.74 vs. EVHC: 214.84 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
EVHC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 51.69  Med: 127.98 Max: 226.96
Current: 214.84
51.69
226.96
Revenue Growth (3Y)(%) 19.20
EVHC's Revenue Growth (3Y)(%) is ranked higher than
86% of the 181 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. EVHC: 19.20 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
EVHC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 10.3  Med: 15.3 Max: 19.4
Current: 19.2
10.3
19.4
EBITDA Growth (3Y)(%) 12.00
EVHC's EBITDA Growth (3Y)(%) is ranked higher than
66% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 7.40 vs. EVHC: 12.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
EVHC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -9  Med: 11.95 Max: 41.3
Current: 12
-9
41.3
EPS Growth (3Y)(%) 18.70
EVHC's EPS Growth (3Y)(%) is ranked higher than
70% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. EVHC: 18.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
EVHC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.2  Med: 11 Max: 135.1
Current: 18.7
-7.2
135.1
» EVHC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q4 2015

EVHC Guru Trades in Q4 2015

Steven Cohen 582,300 sh (New)
Joel Greenblatt 16,641 sh (+196.58%)
Jim Simons 435,600 sh (+116.72%)
Vanguard Health Care Fund 9,029,230 sh (+53.53%)
Columbia Wanger 1,504,277 sh (+18.67%)
Alan Fournier Sold Out
Andreas Halvorsen 7,808,316 sh (-20.77%)
Paul Tudor Jones 36,222 sh (-59.81%)
» More
Q1 2016

EVHC Guru Trades in Q1 2016

George Soros 41,800 sh (New)
Jim Simons 1,283,600 sh (+194.67%)
Steven Cohen 1,221,300 sh (+109.74%)
Vanguard Health Care Fund 10,993,895 sh (+21.76%)
Columbia Wanger Sold Out
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Andreas Halvorsen 5,122,097 sh (-34.40%)
» More
Q2 2016

EVHC Guru Trades in Q2 2016

Paul Tudor Jones 34,925 sh (New)
Andreas Halvorsen 7,817,258 sh (+52.62%)
Vanguard Health Care Fund 10,993,895 sh (unchged)
George Soros Sold Out
Jim Simons 695,500 sh (-45.82%)
Steven Cohen 55,400 sh (-95.46%)
» More
Q3 2016

EVHC Guru Trades in Q3 2016

Mario Gabelli 30,000 sh (New)
Jeremy Grantham 2,429,000 sh (New)
Vanguard Health Care Fund 10,993,895 sh (unchged)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Andreas Halvorsen 3,419,495 sh (-56.26%)
Jim Simons 227,900 sh (-67.23%)
» More
» Details

Insider Trades

Latest Guru Trades with EVHC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Envision Healthcare Corp

SymbolPriceYieldDescription
EVHCPR135.063.89

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:HLS, NAS:ACHC, NYSE:CHE, OTCPK:LTGHY, NAS:LPNT, NAS:WOOF, NAS:SCAI, NYSE:SEM, NYSE:THC, NYSE:AMN, NAS:AMED, NAS:PAHC, NYSE:MD, NAS:HWAY, NAS:LHCG, NAS:SGRY, NYSE:USPH, NYSE:CYH, OTCPK:RLGHF, NAS:PRSC » details
Traded in other countries:AJH.Germany,
Amsurg Corp owns and operates ambulatory surgery centers. The Company acquire, develops and operates ASCs through the formation of partnership with physicians to serve the communities in its markets.

Amsurg Corp was formed in 1992. The Company owns and operates short stay ambulatory surgery centers or "ASC"s in the United States. The Company acquires, develops and operates ASCs through the formation of strategic partnerships with physicians to serve the communities in its markets. The Company has developed its operating model to encourage physicians to affiliate with them. It operates 242 surgery centers in 34 states and the District of Columbia. As of December 31, 2013, 151 of its centers performed gastrointestinal endoscopy procedures, 48 centers were multi-specialty centers, 36 centers performed ophthalmology surgery procedures and seven centers performed orthopaedic procedures. The Company market its surgery centers directly to patients, referring physicians and third party payors, including health maintenance organizations, or "HMO"s, preferred provider organizations, or "PPO"s, other managed care organizations, and employers. The Company competes with hospitals and other surgery centers in recruiting physicians to utilize its surgery centers, for patients and for the opportunity to contract with payors. The healthcare industry is subject to extensive regulation by a number of governmental entities at the federal, state and local level.

Top Ranked Articles about Envision Healthcare Corp

Allergan Among Health Care Holdings in Alan Fournier's Portfolio The sector is 17.50% of his portfolio, and Allergan is the most heavily weighted stake
Alan Fournier (Trades, Portfolio) manages Pennant Master Fund,Pennant Windward Master Fund, Broadway Gate Master Fund Ltd. and Pennant General Partner LLC. He manages a portfolio composed of 36 stocks with a total value of $4.731 billion. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 334.69
EVHC's P/E(ttm) is ranked higher than
63% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 25.07 vs. EVHC: 334.69 )
Ranked among companies with meaningful P/E(ttm) only.
EVHC' s P/E(ttm) Range Over the Past 10 Years
Min: 9.06  Med: 17.82 Max: 354.84
Current: 334.69
9.06
354.84
Forward P/E 14.68
EVHC's Forward P/E is ranked higher than
68% of the 53 Companies
in the Global Medical Care industry.

( Industry Median: 16.18 vs. EVHC: 14.68 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 334.69
EVHC's PE(NRI) is ranked higher than
65% of the 194 Companies
in the Global Medical Care industry.

( Industry Median: 25.14 vs. EVHC: 334.69 )
Ranked among companies with meaningful PE(NRI) only.
EVHC' s PE(NRI) Range Over the Past 10 Years
Min: 8.6  Med: 18.08 Max: 354.84
Current: 334.69
8.6
354.84
P/B 19.44
EVHC's P/B is ranked higher than
67% of the 231 Companies
in the Global Medical Care industry.

( Industry Median: 2.39 vs. EVHC: 19.44 )
Ranked among companies with meaningful P/B only.
EVHC' s P/B Range Over the Past 10 Years
Min: 0.93  Med: 1.7 Max: 20.62
Current: 19.44
0.93
20.62
P/S 6.47
EVHC's P/S is ranked higher than
58% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.45 vs. EVHC: 6.47 )
Ranked among companies with meaningful P/S only.
EVHC' s P/S Range Over the Past 10 Years
Min: 0.7  Med: 1.27 Max: 6.85
Current: 6.47
0.7
6.85
PFCF 271.53
EVHC's PFCF is ranked higher than
87% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 23.72 vs. EVHC: 271.53 )
Ranked among companies with meaningful PFCF only.
EVHC' s PFCF Range Over the Past 10 Years
Min: 2.21  Med: 4.89 Max: 287.85
Current: 271.53
2.21
287.85
POCF 134.18
EVHC's POCF is ranked higher than
80% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 14.12 vs. EVHC: 134.18 )
Ranked among companies with meaningful POCF only.
EVHC' s POCF Range Over the Past 10 Years
Min: 2  Med: 4.42 Max: 142.23
Current: 134.18
2
142.23
EV-to-EBIT 117.83
EVHC's EV-to-EBIT is ranked higher than
87% of the 190 Companies
in the Global Medical Care industry.

( Industry Median: 19.66 vs. EVHC: 117.83 )
Ranked among companies with meaningful EV-to-EBIT only.
EVHC' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.5  Med: 7.1 Max: 124.44
Current: 117.83
3.5
124.44
EV-to-EBITDA 70.82
EVHC's EV-to-EBITDA is ranked higher than
81% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. EVHC: 70.82 )
Ranked among companies with meaningful EV-to-EBITDA only.
EVHC' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.2  Med: 6.4 Max: 74.79
Current: 70.82
3.2
74.79
PEG 1.90
EVHC's PEG is ranked higher than
66% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 2.64 vs. EVHC: 1.90 )
Ranked among companies with meaningful PEG only.
EVHC' s PEG Range Over the Past 10 Years
Min: 0.3  Med: 1.16 Max: 5.83
Current: 1.9
0.3
5.83
Current Ratio 1.65
EVHC's Current Ratio is ranked higher than
63% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.28 vs. EVHC: 1.65 )
Ranked among companies with meaningful Current Ratio only.
EVHC' s Current Ratio Range Over the Past 10 Years
Min: 1.37  Med: 3.22 Max: 4.94
Current: 1.65
1.37
4.94
Quick Ratio 1.59
EVHC's Quick Ratio is ranked higher than
67% of the 252 Companies
in the Global Medical Care industry.

( Industry Median: 1.15 vs. EVHC: 1.59 )
Ranked among companies with meaningful Quick Ratio only.
EVHC' s Quick Ratio Range Over the Past 10 Years
Min: 1.32  Med: 3.01 Max: 4.62
Current: 1.59
1.32
4.62
Days Inventory 40.60
EVHC's Days Inventory is ranked lower than
71% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 18.12 vs. EVHC: 40.60 )
Ranked among companies with meaningful Days Inventory only.
EVHC' s Days Inventory Range Over the Past 10 Years
Min: 10.86  Med: 12.24 Max: 42.64
Current: 40.6
10.86
42.64
Days Sales Outstanding 51.53
EVHC's Days Sales Outstanding is ranked lower than
62% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 42.10 vs. EVHC: 51.53 )
Ranked among companies with meaningful Days Sales Outstanding only.
EVHC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.74  Med: 39.98 Max: 52.45
Current: 51.53
34.74
52.45
Days Payable 50.94
EVHC's Days Payable is ranked higher than
55% of the 164 Companies
in the Global Medical Care industry.

( Industry Median: 38.65 vs. EVHC: 50.94 )
Ranked among companies with meaningful Days Payable only.
EVHC' s Days Payable Range Over the Past 10 Years
Min: 18.16  Med: 21.43 Max: 65.73
Current: 50.94
18.16
65.73

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -19.30
EVHC's 3-Year Average Share Buyback Ratio is ranked lower than
84% of the 127 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. EVHC: -19.30 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
EVHC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -19.3  Med: -1.6 Max: 1.2
Current: -19.3
-19.3
1.2

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 0.55
EVHC's Price/Projected FCF is ranked higher than
93% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 1.64 vs. EVHC: 0.55 )
Ranked among companies with meaningful Price/Projected FCF only.
EVHC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.24  Med: 0.57 Max: 2.52
Current: 0.55
0.24
2.52
Price/DCF (Earnings Based) 1.78
EVHC's Price/DCF (Earnings Based) is ranked lower than
61% of the 31 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. EVHC: 1.78 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.98
EVHC's Price/Median PS Value is ranked higher than
58% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 1.00 vs. EVHC: 0.98 )
Ranked among companies with meaningful Price/Median PS Value only.
EVHC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.52  Med: 1.09 Max: 2.2
Current: 0.98
0.52
2.2
Price/Peter Lynch Fair Value 1.79
EVHC's Price/Peter Lynch Fair Value is ranked higher than
64% of the 42 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. EVHC: 1.79 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
EVHC' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.4  Med: 1.19 Max: 4.93
Current: 1.79
0.4
4.93
Earnings Yield (Greenblatt) (%) 0.85
EVHC's Earnings Yield (Greenblatt) (%) is ranked higher than
91% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 3.80 vs. EVHC: 0.85 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
EVHC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.81  Med: 14.2 Max: 28.6
Current: 0.85
0.81
28.6
Forward Rate of Return (Yacktman) (%) 24.68
EVHC's Forward Rate of Return (Yacktman) (%) is ranked higher than
83% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 10.28 vs. EVHC: 24.68 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
EVHC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.3  Med: 26.3 Max: 59.2
Current: 24.68
9.3
59.2

More Statistics

Revenue (TTM) (Mil) $3,010
EPS (TTM) $ 3.29
Beta0.41
Short Percentage of Float33.17%
52-Week Range $18.31 - 84.71
Shares Outstanding (Mil)54.80

Analyst Estimate

Dec16 Dec17
Revenue (Mil $)
EPS ($) 4.31 4.85
EPS w/o NRI ($) 4.31 4.85
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for EVHC

Headlines

Articles On GuruFocus.com
Howard Marks' Largest Trades in Second Quarter Sep 29 2015 
Howard Marks Buys 13 New Stocks in Q3 Nov 14 2014 
Weekly CFO Sells Highlight: V, SCLN, VR, AMSG Jun 25 2012 
AmSurg Corp: Free Cash Flow not what it seems (AMSG) Aug 04 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares Mar 17 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 27,500 Shares Nov 12 2010 
Amsurg Corp. Reports Operating Results (10-Q) Nov 05 2010 
Amsurg Corp. Reports Operating Results (10-Q) May 09 2009 

More From Other Websites
ENVISION HEALTHCARE CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination... Dec 07 2016
Envision Healthcare upgraded by Oppenheimer Dec 07 2016
Envision Healthcare Ties Up with Alabama Neonatal Medicine Dec 06 2016
Envision Healthcare to Present at Citi 2016 Global Healthcare Conference on December 7, 2016 Dec 05 2016
4:16 pm Envision Healthcare acquires Alabama Neonatal Medicine; terms not disclosed Dec 05 2016
Envision Healthcare’s Physician Services Business Acquires Alabama Neonatal Medicine, P.C. Dec 05 2016
Envision Healthcare Triples on Completed Merger Dec 02 2016
ENVISION HEALTHCARE CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 01 2016
Envision Healthcare and AMSURG Complete Transformational Merger Dec 01 2016
Live Nation Entertainment, Inc. (LYV): Are Hedge Funds Right About This Stock? Dec 01 2016
Is Alnylam Pharmaceuticals, Inc. (ALNY) A Good Stock To Buy Right Now? Nov 30 2016
Is Envision Healthcare Holdings Inc (EVHC) a Good Stock to Buy? Nov 30 2016
Mid-America Apartment Communities, AmSurg to Join S&P 500; Others to Join S&P MidCap 400 and S&P... Nov 29 2016
Envision (EVHC) & AMSURG Merger Okayed by Shareholders Nov 29 2016
ENVISION HEALTHCARE HOLDINGS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Nov 28 2016
Envision Healthcare and AMSURG Shareholders Approve Merger Nov 28 2016
ENVISION HEALTHCARE HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Nov 17 2016
Should You Follow Sachem Head’s Stock Picks: CDK Global Inc (CDK), FleetCor Technologies, Inc.... Nov 17 2016
ENVISION HEALTHCARE HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and... Nov 16 2016
Envision and AMSURG Announce Pricing of $550 Million Senior Notes Offering by New Amethyst Corp. (To... Nov 16 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)